3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice

被引:67
|
作者
Trigo, Jose Manuel
Renoir, Thibault
Lanfumey, Laurence
Hamon, Michel
Lesch, Klaus-Peter
Robledo, Patricia
Maldonado, Rafael
机构
[1] Univ Pompeu Fabra, E-08003 Barcelona, Spain
[2] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Lab Neurofarmacol, Barcelona, Spain
[3] Univ Paris 06, INSERM 677, IFR 70 Neurosci, Paris, France
[4] Inst Municipal Invest Med, Barcelona, Spain
[5] Univ Wurzburg, Dept Psychiat & Psychotherapy, Wurzburg, Germany
关键词
5-HT; DA; ecstasy; food and water operant responding; in vivo microdialysis; nucleus accumbens; prefrontal cortex;
D O I
10.1016/j.biopsych.2006.11.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The neurobiological mechanism underlying the reinforcing effects of 3,4-methylenedioxymethamphetamine (MDMA) remains unclear. The aim of the present study was to determine the contribution of the serotonin transporter (SERT) in MDMA selfadministration behavior by using knockout (KC) mice deficient in SERT. Methods: Knockout mice and wild-type (WT) littermates were trained to acquire intravenous self-administration of MDMA (0, .03, .06, .125,, and .25 mg/kg/infusion) on a fixed ratio 1 (FRI) schedule of reinforcement. Additional groups of mice were trained to obtain food and water to rule out operant responding impairments. Microdialysis studies were performed to evaluate dopamine (DA) and serotonin (5-HT) extracellular levels in the nucleus accumbens (NAC) and prefrontal cortex (PFC), respectively, after acute MDMA (10 mg/kg). Results: None of the MDMA doses tested maintained intravenous self-administration in KO animals, whereas WT mice acquired responding for MDMA. Acquisition of operant responding for food and water was delayed in KO mice, but no differences between genotypes were observed on the last day of training. MDMA increased DA extracellular levels to a similar extent in the NAC of WT and KO mice. Conversely, extracellular concentrations of 5-HT in the PFC were increased following MDMA only in WT mice. Conclusions: These findings provide evidence for the specific involvement of SERT in MDMA reinforcing properties.
引用
收藏
页码:669 / 679
页数:11
相关论文
共 50 条
  • [31] Pro-social effects of 3,4-methylenedioxymethamphetamine in mice
    Curry, Daniel Walker
    Murnane, Kevin Sean
    Howell, Leonard Lee
    FASEB JOURNAL, 2012, 26
  • [33] (±)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane
    Wang, XY
    Baumann, MH
    Xu, H
    Morales, M
    Rothman, RB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03): : 1002 - 1012
  • [34] In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") and Hallucinogen Users
    Erritzoe, David
    Frokjaer, Vibe G.
    Holst, Klaus K.
    Christoffersen, Maria
    Johansen, Sys S.
    Svarer, Claus
    Madsen, Jacob
    Rasmussen, Peter M.
    Ramsoy, Thomas
    Jernigan, Terry L.
    Knudsen, Gitte M.
    ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (06) : 562 - 576
  • [35] Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration
    Porceddu, Pier Francesca
    Ishola, Ismail Ogunbayode
    Contu, Liliana
    Morelli, Micaela
    NEUROTOXICITY RESEARCH, 2016, 30 (01) : 101 - 109
  • [36] 3,4-methylenedioxymethamphetamine (mdma): A review
    O’Leary G.
    Nargiso J.
    Weiss R.D.
    Current Psychiatry Reports, 2001, 3 (6) : 477 - 483
  • [37] 3,4-Methylenedioxymethamphetamine as a Psychiatric Treatment
    Bedi, Gillinder
    JAMA PSYCHIATRY, 2018, 75 (05) : 419 - 420
  • [38] Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration
    Kolbrich, Erin A.
    Goodwin, Robert S.
    Gorelick, David A.
    Hayes, Robert J.
    Stein, Elliot A.
    Huestis, Marilyn A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (04) : 432 - 440
  • [39] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [40] LACK OF SEROTONIN NEUROTOXICITY AFTER INTRARAPHE MICROINJECTION OF (+)-3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA)
    PARIS, JM
    CUNNINGHAM, KA
    BRAIN RESEARCH BULLETIN, 1992, 28 (01) : 115 - 119